{
  "id": "3c2006f7bd9cc374",
  "title": "Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor",
  "description": "20251229T140000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/29/tmt-newswire/globenewswire/praxis-precision-medicines-announces-the-fda-has-granted-breakthrough-therapy-designation-for-ulixacaltamide-hcl-in-essential-tremor/2250420",
  "published_at": "20251229T140000Z",
  "fetched_at": "2025-12-30T00:22:59.073919+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/29/tmt-newswire/globenewswire/praxis-precision-medicines-announces-the-fda-has-granted-breakthrough-therapy-designation-for-ulixacaltamide-hcl-in-essential-tremor/2250420",
    "url_mobile": "https://www.manilatimes.net/2025/12/29/tmt-newswire/globenewswire/praxis-precision-medicines-announces-the-fda-has-granted-breakthrough-therapy-designation-for-ulixacaltamide-hcl-in-essential-tremor/2250420/amp",
    "title": "Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor",
    "seendate": "20251229T140000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/29/882550.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}